4//SEC Filing
SAMET KENNETH A 4
Accession 0001628908-19-000062
CIK 0001628908other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:06 PM ET
Size
5.2 KB
Accession
0001628908-19-000062
Insider Transaction Report
Form 4
SAMET KENNETH A
Director
Transactions
- Purchase
Class A Common Stock
2019-08-15$7.04/sh+7,200$50,688→ 39,235 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average. These shares were purchased in multiple transactions at prices ranging from $7.03-$7.05, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeother
Related Parties
1- filerCIK 0001359252
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 4:06 PM ET
- Size
- 5.2 KB